Cargando…

Tuberculosis control, and the where and why of artificial intelligence

Countries aiming to reduce their tuberculosis (TB) burden by 2035 to the levels envisaged by the World Health Organization End TB Strategy need to innovate, with approaches such as digital health (electronic and mobile health) in support of patient care, surveillance, programme management, training...

Descripción completa

Detalles Bibliográficos
Autores principales:	Doshi, Riddhi, Falzon, Dennis, Thomas, Bruce V., Temesgen, Zelalem, Sadasivan, Lal, Migliori, Giovanni Battista, Raviglione, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478795/ https://www.ncbi.nlm.nih.gov/pubmed/28656130 http://dx.doi.org/10.1183/23120541.00056-2017

Ejemplares similares

Numbers needed to treat to prevent tuberculosis
por: Matteelli, Alberto, et al.
Publicado: (2015)

Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives
por: Pontali, Emanuele, et al.
Publicado: (2019)

Mandatory tuberculosis case notification in high tuberculosis-incidence countries: policy and practice
por: Uplekar, Mukund, et al.
Publicado: (2016)

Global reporting on tuberculosis preventive treatment among contacts
por: Falzon, Dennis, et al.
Publicado: (2022)

The Internet of Things to come: digital technologies and the End TB Strategy
por: Falzon, Dennis, et al.
Publicado: (2016)

Tuberculosis elimination: where are we now?
por: Matteelli, Alberto, et al.
Publicado: (2018)

Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis
por: Campbell, Jonathon R., et al.
Publicado: (2020)

Extensively Drug-resistant Tuberculosis, Italy and Germany
por: Migliori, Giovanni Battista, et al.
Publicado: (2007)

Artificial Intelligence in Emergency Radiology: Where Are We Going?
por: Cellina, Michaela, et al.
Publicado: (2022)

Digital health for the End TB Strategy: developing priority products and making them work
por: Falzon, Dennis, et al.
Publicado: (2016)

Artificial Intelligence in Digestive Endoscopy—Where Are We and Where Are We Going?
por: Vulpoi, Radu-Alexandru, et al.
Publicado: (2022)

Artificial intelligence in gastroenterology: Where are we heading?
por: Koleth, Glenn, et al.
Publicado: (2022)

Post-tuberculosis sequelae and their socioeconomic consequences: worth investigating
por: Sotgiu, Giovanni, et al.
Publicado: (2021)

Celebrating TB day at the time of COVID-19
por: Alagna, Riccardo, et al.
Publicado: (2020)

Multidrug-resistant tuberculosis around the world: what progress has been made?
por: Falzon, Dennis, et al.
Publicado: (2015)

Monitoring Therapy Adherence of Tuberculosis Patients by using Video-Enabled Electronic Devices
por: Story, Alistair, et al.
Publicado: (2016)

The Last Mile: Where Artificial Intelligence Meets Reality
por: Coiera, Enrico
Publicado: (2019)

Artificial Intelligence and Infectious Keratitis: Where Are We Now?
por: Soleimani, Mohammad, et al.
Publicado: (2023)

Artificial intelligence in radiology: friend or foe? Where are we now and where are we heading?
por: Pakdemirli, Emre
Publicado: (2019)

Artificial intelligence in colonoscopy: where have we been and where should we go?
por: Mohan, Babu P., et al.
Publicado: (2023)

Tuberculosis series 2020
por: Silva, Denise Rossato, et al.
Publicado: (2020)

Tuberculosis series 2019
por: Silva, Denise Rossato, et al.
Publicado: (2019)

Tuberculosis Series 2021
por: Silva, Denise Rossato, et al.
Publicado: (2021)

Artificial Intelligence in Paediatric Tuberculosis
por: Naidoo, Jaishree, et al.
Publicado: (2023)

Application of Artificial Intelligence in Capsule Endoscopy: Where Are We Now?
por: Hwang, Youngbae, et al.
Publicado: (2018)

Artificial Intelligence Applications in Dermatology: Where Do We Stand?
por: Gomolin, Arieh, et al.
Publicado: (2020)

Radiomics based on artificial intelligence in liver diseases: where are we?
por: Hu, Wenmo, et al.
Publicado: (2020)

The Artificial Intelligence in Digital Pathology and Digital Radiology: Where Are We?
por: Giansanti, Daniele
Publicado: (2020)

Big Data and Artificial Intelligence in Ophthalmology: Where Are We Now?
por: Lee, Cecilia S., et al.
Publicado: (2021)

Artificial Intelligence for Thyroid Nodule Characterization: Where Are We Standing?
por: Sorrenti, Salvatore, et al.
Publicado: (2022)

Artificial intelligence and inflammatory bowel disease: Where are we going?
por: Da Rio, Leonardo, et al.
Publicado: (2023)

Modernizing Surveillance of Antituberculosis Drug Resistance: From Special Surveys to Routine Testing
por: Zignol, Matteo, et al.
Publicado: (2011)

Shortened tuberculosis treatment regimens: what is new?
por: Silva, Denise Rossato, et al.
Publicado: (2020)

Diagnosis and management of post-tuberculosis lung disease
por: Silva, Denise Rossato, et al.
Publicado: (2023)

Synchronous and asynchronous video observed therapy (VOT) for tuberculosis treatment adherence monitoring and support
por: Garfein, Richard S., et al.
Publicado: (2019)

The definition of tuberculosis infection based on the spectrum of tuberculosis disease
por: Migliori, Giovanni Battista, et al.
Publicado: (2021)

Where Is the Artificial Intelligence Applied in Dentistry? Systematic Review and Literature Analysis
por: Thurzo, Andrej, et al.
Publicado: (2022)

Tuberculosis in the time of COVID-19: quality of life and digital innovation
por: Visca, Dina, et al.
Publicado: (2020)

Effects of COVID-19 on tuberculosis control: past, present, and future
por: Silva, Denise Rossato, et al.
Publicado: (2022)

COVID-19 Related Hospital Re-organization and Trends in Tuberculosis Diagnosis and Admissions: Reflections From Portugal
por: Alves, Adelaide, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o56dffelibcerhd1vqfuei9emm